Screener
Bicara Therapeutics BCAX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $323,462 | $96,685 |
| Prepaid expenses and other assets | 5,162 | 7,252 |
| Marketable securities | 216,291 | 318,116 |
| Total current assets | 544,915 | 422,053 |
| Property and equipment, net | 346 | 330 |
| Right of use asset – operating lease | 1,428 | 1,701 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bicara Therapeutics's prepaid & other current?
- Bicara Therapeutics (BCAX) reported prepaid & other current of $5.16M in Q1 2026.
- How has Bicara Therapeutics's prepaid & other current changed year-over-year?
- Bicara Therapeutics's prepaid & other current decreased by 40.6% year-over-year, from $8.69M to $5.16M.
- What is the long-term trend for Bicara Therapeutics's prepaid & other current?
- Over 2 years (2023 to 2025), Bicara Therapeutics's prepaid & other current has grown at a 238.5% compound annual growth rate (CAGR), from $633K to $7.25M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Bicara Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude